Review



dopamine d 4 receptor  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Alomone Labs dopamine d 4 receptor
    Synaptosomal receptor expression (% of saline control with pump). Bolded indicates significant interaction between Saline/Nicotine vs. Pump On/Pump Off. Effect of chronic nicotine (40 mg/kg/day) treatment on mGluR1, mGluR5, and <t> dopamine D 4 receptor </t> expression. After 33 days of chronic nicotine treatment (“Pump On”) and 4 h after pump removal (“Pump Off”), a subset of WT mice were removed and levels of synaptosomal mGluR1, mGluR5 and, D 4 receptor expression were analyzed. There was a significant effect of nicotine on mGluR1 expression during nicotine administration and during withdrawal. Significant interactions between synaptosomal expression during nicotine (Pump On) and withdrawal (Pump Off) for mGluR5 (trend) and dopamine D 4 receptors were observed, though no significant post hoc differences between levels were observed.
    Dopamine D 4 Receptor, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dopamine d 4 receptor/product/Alomone Labs
    Average 90 stars, based on 2 article reviews
    dopamine d 4 receptor - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice"

    Article Title: Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice

    Journal: Psychopharmacology

    doi: 10.1007/s00213-017-4572-2

    Synaptosomal receptor expression (% of saline control with pump). Bolded indicates significant interaction between Saline/Nicotine vs. Pump On/Pump Off. Effect of chronic nicotine (40 mg/kg/day) treatment on mGluR1, mGluR5, and dopamine D 4 receptor expression. After 33 days of chronic nicotine treatment (“Pump On”) and 4 h after pump removal (“Pump Off”), a subset of WT mice were removed and levels of synaptosomal mGluR1, mGluR5 and, D 4 receptor expression were analyzed. There was a significant effect of nicotine on mGluR1 expression during nicotine administration and during withdrawal. Significant interactions between synaptosomal expression during nicotine (Pump On) and withdrawal (Pump Off) for mGluR5 (trend) and dopamine D 4 receptors were observed, though no significant post hoc differences between levels were observed.
    Figure Legend Snippet: Synaptosomal receptor expression (% of saline control with pump). Bolded indicates significant interaction between Saline/Nicotine vs. Pump On/Pump Off. Effect of chronic nicotine (40 mg/kg/day) treatment on mGluR1, mGluR5, and dopamine D 4 receptor expression. After 33 days of chronic nicotine treatment (“Pump On”) and 4 h after pump removal (“Pump Off”), a subset of WT mice were removed and levels of synaptosomal mGluR1, mGluR5 and, D 4 receptor expression were analyzed. There was a significant effect of nicotine on mGluR1 expression during nicotine administration and during withdrawal. Significant interactions between synaptosomal expression during nicotine (Pump On) and withdrawal (Pump Off) for mGluR5 (trend) and dopamine D 4 receptors were observed, though no significant post hoc differences between levels were observed.

    Techniques Used: Expressing



    Similar Products

    dopamine d 4 receptor  (Alomone Labs)
    90
    Alomone Labs dopamine d 4 receptor
    Synaptosomal receptor expression (% of saline control with pump). Bolded indicates significant interaction between Saline/Nicotine vs. Pump On/Pump Off. Effect of chronic nicotine (40 mg/kg/day) treatment on mGluR1, mGluR5, and <t> dopamine D 4 receptor </t> expression. After 33 days of chronic nicotine treatment (“Pump On”) and 4 h after pump removal (“Pump Off”), a subset of WT mice were removed and levels of synaptosomal mGluR1, mGluR5 and, D 4 receptor expression were analyzed. There was a significant effect of nicotine on mGluR1 expression during nicotine administration and during withdrawal. Significant interactions between synaptosomal expression during nicotine (Pump On) and withdrawal (Pump Off) for mGluR5 (trend) and dopamine D 4 receptors were observed, though no significant post hoc differences between levels were observed.
    Dopamine D 4 Receptor, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dopamine d 4 receptor/product/Alomone Labs
    Average 90 stars, based on 1 article reviews
    dopamine d 4 receptor - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    d 4 dopamine receptor agonist abt-724  (AbbVie Inc)
    90
    AbbVie Inc d 4 dopamine receptor agonist abt-724
    Targets of first wave of donated probes (approved or close to approval).
    D 4 Dopamine Receptor Agonist Abt 724, supplied by AbbVie Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d 4 dopamine receptor agonist abt-724/product/AbbVie Inc
    Average 90 stars, based on 1 article reviews
    d 4 dopamine receptor agonist abt-724 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Synaptosomal receptor expression (% of saline control with pump). Bolded indicates significant interaction between Saline/Nicotine vs. Pump On/Pump Off. Effect of chronic nicotine (40 mg/kg/day) treatment on mGluR1, mGluR5, and dopamine D 4 receptor expression. After 33 days of chronic nicotine treatment (“Pump On”) and 4 h after pump removal (“Pump Off”), a subset of WT mice were removed and levels of synaptosomal mGluR1, mGluR5 and, D 4 receptor expression were analyzed. There was a significant effect of nicotine on mGluR1 expression during nicotine administration and during withdrawal. Significant interactions between synaptosomal expression during nicotine (Pump On) and withdrawal (Pump Off) for mGluR5 (trend) and dopamine D 4 receptors were observed, though no significant post hoc differences between levels were observed.

    Journal: Psychopharmacology

    Article Title: Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice

    doi: 10.1007/s00213-017-4572-2

    Figure Lengend Snippet: Synaptosomal receptor expression (% of saline control with pump). Bolded indicates significant interaction between Saline/Nicotine vs. Pump On/Pump Off. Effect of chronic nicotine (40 mg/kg/day) treatment on mGluR1, mGluR5, and dopamine D 4 receptor expression. After 33 days of chronic nicotine treatment (“Pump On”) and 4 h after pump removal (“Pump Off”), a subset of WT mice were removed and levels of synaptosomal mGluR1, mGluR5 and, D 4 receptor expression were analyzed. There was a significant effect of nicotine on mGluR1 expression during nicotine administration and during withdrawal. Significant interactions between synaptosomal expression during nicotine (Pump On) and withdrawal (Pump Off) for mGluR5 (trend) and dopamine D 4 receptors were observed, though no significant post hoc differences between levels were observed.

    Article Snippet: Blots were probed with primary antibodies overnight in a cold room using anti-mGluR1 (#ab27199 from Abcam, Cambridge, MA), mGluR5 (#ab76316 from Abcam), and dopamine D 4 receptor (#ADR-004, from Alomone Labs, Jerusalem, Israel) antibodies.

    Techniques: Expressing

    Targets of first wave of donated probes (approved or close to approval).

    Journal: eLife

    Article Title: Donated chemical probes for open science

    doi: 10.7554/eLife.34311

    Figure Lengend Snippet: Targets of first wave of donated probes (approved or close to approval).

    Article Snippet: , D 4 Dopamine receptor , Agonist , AbbVie ABT-724 , .

    Techniques: Migration, Binding Assay, Protease Inhibitor